Partow Kebriaei, MD, discusses when the optimal time for transplant is in patients with acute lymphoblastic leukemia.
Partow Kebriaei, MD
Advertisement
Partow Kebriaei, MD, works at the Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, at MD Anderson Cancer Center.
Articles by Partow Kebriaei, MD
Partow Kebriaei, MD, discusses what factors may influence the decision for transplant in patients with acute lymphoblastic leukemia and how experts determine who is best fit for transplant.
Partow Kebriaei, MD, discusses transplant in acute lymphoblastic leukemia.
Advertisement
Latest Updated Articles
Transplant in ALL: Tailoring Treatment Based on MRDPublished: September 5th 2024 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
4
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
5
